Evidence map›Paper›PMID 24049631›Full record

ArticleClinical investigation2013

Genetic biomarkers of placebo response: what could it mean for future trial design?

Kathryn T Hall, Ted J Kaptchuk

Abstract read
In one paragraph

Article in Clinical investigation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Unanticipated Insights into Biomedicine from the Study of Acupuncture.Journal of alternative and complementary medicine (New York, N.Y.) · 2016
    Article
  5. Genetics and the placebo effect: the placebome.Trends in molecular medicine · 2015
    Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kathryn T HallProgram in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA ; Division of General Medicine & Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Ted J Kaptchuk

Funding

Research Training in Complementary and Integrative MedicineT32AT000051 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GLORIA Y YEH · 1999 to 2026
$10.2M
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel SyndroR01AT004662 · NCCIH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAPTCHUK, TED, KOKKOTOU, EFI G. · 2009 to 2013
$2.3M
Mentoring and Research in Placebo Studies, Asian Medicine, and CAMK24AT004095 · NCCIH · HARVARD MEDICAL SCHOOL · PI KAPTCHUK, TED · 2007 to 2016
$1.4M
NCCIH NIH HHS K24 AT004095NCCIH NIH HHS R01 AT004662NCCIH NIH HHS T32 AT000051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersCOMTdoctor–patientenrichment strategiesplacebo effectrandomized controlled trialVal158Met

Identifiers

PMID24049631
PMCPMC3774308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.